CD4 and glioblastoma: Nagle et al. implemented a human-specific CD4 scFv-CH3 fragment (minibody, Mb, ~80 kDa) radiolabeled with 64Cu to follow human CD4+ T cell migration into a patient-derived glioblastoma 45.